Paul J Kammermeier

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Escherichia Coli

Electron Transfer

Magnetic Resonance Imaging

Top Venues

Molecular pharmacology

bioRxiv : the preprint server for biology

Pharmacology research & perspectives

This page only lists publications with an associated author ORCID identifier.

Publications

Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling Specificity and Kinetics of the Human Metabotropic Glutamate Receptors. Molecular pharmacology 105 (2) (2024)
Tyler W McCullock, Loren P Cardani, Paul J Kammermeier
Signaling specificity and kinetics of the human metabotropic glutamate receptors. bioRxiv : the preprint server for biology (2023)
Tyler W McCullock, Paul J Kammermeier
Target validation: Weak selectivity of LY341495 for mGluR2 over mGluR4 makes glutamate a less selective agonist. Pharmacology research & perspectives 7 (3) (2019)